Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/IMM stock hub

AIM/IMM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/IMMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
25.9M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/IMM
In the news

Latest news · AIM/IMM

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-259.9
P25 -54.2P50 2.1P75 13.7
ROIC-129.7
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/IMM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
162
Groups with data
11
Currency
GBP
Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United Kingdom
Country code
UK
Employees
6
Employees Change
1%
Employees Change Percent
20
Enterprise value
GBX 25.5M
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Biotechnology
Isin
GB0033711010
Last refreshed
2026-05-10
Market cap
GBX 25.9M
Price
GBX 4.15
Price currency
GBX
Sector
Healthcare
Sic
2836
Symbol
aim/IMM
Website
https://www.immupharma.co.uk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-15.2%
EV Earnings
-6.48x
EV/FCF
-13.42x
FCF yield
-7.33%
P/B ratio
76.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Net Income
GBX -3.9M
Net Income Growth Quarters
2%
Net Income Growth Years
3%
Profit Per Employee
GBX -655,754
ROA
-69.57
Roa5y
-53.1
ROCE
-932.9
ROE
-259.9
Roe5y
-289.7
ROIC
-129.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr10y
-17%
Cagr15y
-18.3%
Cagr1y
33.04%
Cagr20y
-12.08%
Cagr3y
13.47%
Cagr5y
-15.05%
EPS Growth Quarters
2
EPS Growth Years
6
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Assets
GBX 1.6M
Cash
GBX 396,648
Current Assets
GBX 1.5M
Current Liabilities
GBX 1.2M
Equity
GBX 336,699
Interest Coverage
-3.55
Liabilities
GBX 1.2M
Long Term Assets
GBX 79,287
Long Term Liabilities
GBX 0
Net Cash
GBX 396,648
Net Cash By Market Cap
GBX 1.53
Net Cash Growth
-63.42%
Net Debt Equity
GBX -1.18
Tangible Book Value
GBX 331,696
Tangible Book Value Per Share
GBX 0
WACC
20.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
1.21
Net Working Capital
GBX -139,236
Quick ratio
0.73
Working Capital
GBX 257,412

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-11.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-84.49%
1Y total return
33.01%
200-day SMA
6.91
3Y total return
46.13%
50-day SMA
5.35
50-day SMA vs 200-day SMA
50under200
5Y total return
-55.76%
All Time High
193.7
All Time High Change
-97.86%
All Time High Date
2018-01-03
All Time Low
0.82
All Time Low Change
404.87%
All Time Low Date
2024-03-01
ATR
0.69
Beta
2.97
Beta1y
1.2
Beta2y
1.07
Ch YTD
-33.06
High
4.79
High52
19.4
High52 Date
2025-09-15
High52ch
-78.61%
Low
4.1
Low52
1.39
Low52 Date
2025-08-13
Low52ch
199.42%
Ma50ch
-22.43%
Price vs 200-day SMA
-39.93%
RSI
39.93
RSI Monthly
48.44
RSI Weekly
38.11
Sharpe ratio
0.85x
Sortino ratio
1.93
Total Return
-11.06%
Tr YTD
-33.06
Tr15y
-95.17%
Tr1m
-8.59%
Tr1w
0.24%
Tr3m
-34.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
GBX -3.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
604,461,892%
Shares Insiders
0.6%
Shares Institutions
87.02%
Shares Out
623,911,379
Shares Qo Q
15.22%
Shares Yo Y
11.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
GBX -1.8M
Average Volume
2,124,517.7x
Bv Per Share
0
CAPEX
GBX -1,652
Ch10y
-84.49
Ch15y
-95.17
Ch1m
-8.59
Ch1w
0.24
Ch1y
33.01
Ch20y
-92.39
Ch3m
-34.95
Ch3y
46.13
Ch5y
-55.76
Ch6m
-60.1
Change
1.22%
Change From Open
-13
Close
4.1
Days Gap
16.34
Depreciation Amortization
5,763
Dollar Volume
7,300,568
Earnings Date
2026-05-19
EBIT
GBX -3.1M
EBITDA
GBX -3.1M
EPS
GBX -0.01
F Score
2
FCF
GBX -1.9M
FCF EV Yield
-7.45x
FCF Per Share
GBX -0
Financing CF
1,394,130
Fiscal Year End
December
Founded
1,999
Income Tax
GBX -199,359
Investing CF
-177,909
Is Primary Listing
1
Last Earnings Date
2025-11-07
Last Report Date
2025-06-30
Ma150
7.24
Ma150ch
-42.7%
Ma20
4.46
Ma20ch
-6.95%
Net CF
-687,792
Next Earnings Date
2026-05-19
Open
4.77
Position In Range
7.3
Ppne
74,284
Price Date
2026-05-08
Ptbv Ratio
78.06
Relative Volume
0.84x
Share Based Comp
-146,096
Tr20y
-92.39%
Tr6m
-60.1%
Volume
1,759,173
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/IMM pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/IMM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+33.0%
S&P 500 1Y: n/a
3Y total return
+46.1%
S&P 500 3Y: n/a
5Y total return
-55.8%
S&P 500 5Y: n/a
10Y total return
-84.5%
S&P 500 10Y: n/a
Ownership

Who owns AIM/IMM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+87.0%
Share of float held by funds and institutions
Insider ownership
+0.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+11.1%
Negative means the company is buying back shares.
Technical

AIM/IMM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
39.9
Neutral momentum band
Price vs 200-day MA
-39.9%
50/200-day relationship not available
Beta (5Y)
2.97
More volatile than the market
Sharpe ratio
0.85
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/IMM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/IMM stock rating?

aim/IMM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/IMM analysis?

The full report lives at /stocks/aim/IMM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/IMM?

The latest report frames aim/IMM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/IMM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.